Carregant...
Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy
BACKGROUND: Doxorubicin‐based chemotherapy after splenectomy remains the standard of care for hemangiosarcoma in dogs, but prognosis is generally poor. HYPOTHESIS/OBJECTIVES: To determine clinical outcome with carboplatin chemotherapy after splenectomy compared to doxorubicin‐based protocols. A seco...
Guardat en:
| Publicat a: | J Vet Intern Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8295674/ https://ncbi.nlm.nih.gov/pubmed/34227148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16212 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|